![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 31/381 | (2006.01) |
A61K 31/4184 | (2006.01) | ||
A61K 31/4196 | (2006.01) | ||
A61K 31/513 | (2006.01) | ||
A61P 31/14 | (2006.01) |
(11) | Number of the document | 2709613 |
(13) | Kind of document | T |
(96) | European patent application number | 12768967.7 |
Date of filing the European patent application | 2012-09-14 | |
(97) | Date of publication of the European application | 2014-03-26 |
(45) | Date of publication and mention of the grant of the patent | 2017-11-29 |
(46) | Date of publication of the claims translation | 2018-02-12 |
(86) | Number | PCT/US2012/055621 |
Date | 2012-09-14 |
(87) | Number | WO 2013/040492 |
Date | 2013-03-21 |
(30) | Number | Date | Country code |
201161535885 P | 2011-09-16 | US | |
201161561753 P | 2011-11-18 | US |
(72) |
RAY, Adrian S., US
WATKINS, William J., US
LINK, John O., US
OLDACH, David W., US
DELANEY, IV, William E., US
|
(73) |
Gilead Pharmasset LLC,
c/o Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, CA 94404,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Žmogaus hepatito viruso (HCV) gydymo būdai |
METHODS FOR TREATING HCV |
Payment date | Validity (years) | Amount | |
2025-07-24 | 14 | 289.00 EUR |
2026-09-14 |